Immunohistochemical analysis of thymic carcinoma focusing on the possibility of molecular targeted and hormonal therapies

M Omatsu, T Kunimura, T Mikogami… - General thoracic and …, 2012 - Springer
Objective Thymic carcinoma is a rare mediastinal malignant tumor, and in many patients, the
tumor is detected in an inoperable advanced stage. Even when chemotherapy is …
被引用次数：16 相关文章 所有 11 个版本

Prognostic factors of patients with thymic carcinoma after surgery: a retrospective analysis of 58 cases

S Wang, Z Wang, X Liu, D Wang, F Liu - World journal of surgery, 2014 - Springer
Background Thymic carcinoma is reputed to carry a poor prognosis. Although few scholars
have studied the prognosis of thymic carcinoma, the prognostic factors of patients after …
被引用次数：5 相关文章 所有 8 个版本
[PDF] annalsofoncology.org

2188P First-line combination of toripalimab and chemotherapy in advanced thymic carcinoma: A prospective, single-arm, phase II trial

H Shi, H Zhu, Y Feng, Y Liu, P Xing… - Annals of …, 2023 - annalsofoncology.org
Background Thymic carcinomas (TCs) are the most aggressive subtype of thymic epithelial
tumors. Chemotherapy is the standard treatment for advanced TCs, although achieved a …
被引用次数：1 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma

T Agatsuma, T Koizumi, S Kanda, M Ito… - Journal of Thoracic …, 2011 - Elsevier
Introduction: Thymic carcinoma is a rare epithelial neoplasm that tends to be aggressive and
metastasize widely. The optimal chemotherapy for unresectable advanced thymic carcinoma …
被引用次数：68 相关文章 所有 14 个版本
[HTML] oup.com

Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies

AC Roden, ES Yi, SD Cassivi… - European Journal of …, 2013 - academic.oup.com
OBJECTIVES Thymic carcinomas have wide ranges of reported survival. Interobserver
agreement on diagnosis might affect prognostical studies. Clinicopathological features of …
被引用次数：39 相关文章 所有 9 个版本
[HTML] mdpi.com

[HTML][HTML] Thymic carcinomas and second malignancies: a single-center review

SS Badve, R Dougherty, M Balatico, KA Kesler… - Cancers, 2021 - mdpi.com
Simple Summary Thymic carcinoma (TC) is a rare neoplasm that accounts for less than
0.01% of all tumors. The aim of our retrospective observational analysis is to review the …
被引用次数：2 相关文章 所有 8 个版本
[HTML] nih.gov

[HTML][HTML] Outcome of nonsurgical treatment for locally advanced thymic tumors

CL Wang, LT Gao, CX Lv, L Zhu… - Journal of Thoracic …, 2016 - ncbi.nlm.nih.gov
Background Surgical resection remains the mainstay of treatment for patients with early-
staged thymic tumors, while chemotherapy is most commonly used in stage IV cases. As for …
被引用次数：19 相关文章 所有 13 个版本
[HTML] nih.gov

[HTML][HTML] Early-stage thymic carcinoma: is adjuvant therapy required?

M Sakai, T Onuki, M Inagaki, M Yamaoka… - Journal of thoracic …, 2013 - ncbi.nlm.nih.gov
Although the prognosis of advanced thymic carconoma remains poor, previous reports have
shown survival rates of 70% to 100% in patients with Masaoka stage I or stage II of the …
被引用次数：14 相关文章 所有 8 个版本
[HTML] frontiersin.org

[HTML][HTML] Thymic squamous cell carcinoma: a population-based surveillance, epidemiology, and end result analysis

X Yang, K Zhao, C Li, Y Yang, C Guo, Y Pu… - Frontiers in …, 2020 - frontiersin.org
Objectives Thymic squamous cell carcinoma (TSCC) is a rare neoplasm that has been
sparsely cited in the literature. The aim of this study was to determine disease characteristics …
被引用次数：12 相关文章 所有 4 个版本
[HTML] nih.gov

Adjuvant chemotherapy improves survival outcomes after complete resection of thymic squamous cell carcinoma: a retrospective study of 116 patients

L Gao, C Wang, M Liu, W Fang, C Lv… - … and Thoracic Surgery, 2021 - academic.oup.com
OBJECTIVES The aim of this study was to evaluate the efficacy of adjuvant chemotherapy
(ACT) for thymic squamous cell carcinoma after completely resection. METHODS Patients …
被引用次数：3 相关文章 所有 7 个版本